J. Safra Sarasin Holding Ag Vera Therapeutics, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.79 Trillion
- Q2 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 29,567 shares of VERA stock, worth $673,831. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,567Holding current value
$673,831% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
64MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$130 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$108 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$76.1 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$67.5 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$66.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $616M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...